Back
Day Range
$75.33
$75.64
52-Week Range
$51.90
$75.75
Volume
2,533,612
50D / 200D Avg
$75.16
/
$70.71
Prev Close
$75.41
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 29.9 | 0.4 |
| P/B | 3.4 | 2.9 |
| ROE % | 11.1 | 3.8 |
| Net Margin % | 13.8 | 3.9 |
| Rev Growth 5Y % | -7.6 | 10.0 |
| D/E | 0.5 | 0.2 |
Key Takeaways
Revenue declined -7.63% annually over 5 years
Earnings declined -28.35% over the past year
ROE of 11.12% — decent returns on equity
Generating 920.10M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9.37%
Cash machine — converts 162.65% of earnings into free cash flow
Growth
Revenue Growth (5Y)
-7.63%
Revenue (1Y)1.74%
Earnings (1Y)-28.35%
FCF Growth (3Y)1.05%
Quality
Return on Equity
11.12%
ROIC6.98%
Net Margin13.80%
Op. Margin17.42%
Safety
Debt / Equity
0.52
Current Ratio3.75
Interest Coverage16.73
Valuation
P/E Ratio
29.85
P/B Ratio3.35
EV/EBITDA24.57
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.74% | Revenue Growth (3Y) | 0.87% |
| Earnings Growth (1Y) | -28.35% | Earnings Growth (3Y) | 11.38% |
| Revenue Growth (5Y) | -7.63% | Earnings Growth (5Y) | -25.85% |
| Profitability | |||
| Revenue (TTM) | 4.10B | Net Income (TTM) | 565.70M |
| ROE | 11.12% | ROA | 6.28% |
| Gross Margin | 61.00% | Operating Margin | 17.42% |
| Net Margin | 13.80% | Free Cash Flow (TTM) | 920.10M |
| ROIC | 6.98% | FCF Growth (3Y) | 1.05% |
| Safety | |||
| Debt / Equity | 0.52 | Current Ratio | 3.75 |
| Interest Coverage | 16.73 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 29.85 | P/B Ratio | 3.35 |
| P/S Ratio | 4.12 | PEG Ratio | -1.06 |
| EV/EBITDA | 24.57 | Dividend Yield | 0.00% |
| Market Cap | 16.89B | Enterprise Value | 17.55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.10B | 4.03B | 4.03B | 4.86B | 5.63B |
| Net Income | 565.70M | 789.50M | 456.00M | 1.30B | 1.87B |
| EPS (Diluted) | 2.49 | 3.32 | 1.83 | 5.13 | 7.21 |
| Gross Profit | 2.50B | 2.23B | 2.07B | 3.00B | 3.80B |
| Operating Income | 714.30M | 882.60M | 668.40M | 1.64B | 2.48B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9.01B | 9.16B | 9.14B | 9.07B | 8.92B |
| Total Liabilities | 3.97B | 4.03B | 4.12B | 4.20B | 4.70B |
| Shareholders' Equity | 5.05B | 5.13B | 5.02B | 4.88B | 4.22B |
| Total Debt | 2.63B | 2.66B | 2.90B | 2.92B | 3.14B |
| Cash & Equivalents | 1.96B | 2.16B | 2.72B | 2.34B | 1.17B |
| Current Assets | 3.67B | 3.82B | 4.18B | 3.86B | 3.17B |
| Current Liabilities | 977.20M | 1.04B | 1.21B | 937.70M | 1.33B |